loadpatents
name:-0.021121025085449
name:-0.010880947113037
name:-0.0004270076751709
Orlek; Barry Sidney Patent Filings

Orlek; Barry Sidney

Patent Applications and Registrations

Patent applications and USPTO patent grants for Orlek; Barry Sidney.The latest application filed is for "1-benzoyl substituted diazepine derivatives as selective histamine h3 receptor agonists".

Company Profile
0.11.20
  • Orlek; Barry Sidney - Harlow N/A GB
  • Orlek; Barry Sidney - Essex GB
  • Orlek; Barry Sidney - Traingle Park NC
  • Orlek, Barry Sidney - Epping GB
  • Orlek, Barry Sidney - Harlow Essex GB
  • Orlek, Barry Sidney - King of Prussia PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
1-benzoyl substituted diazepine derivatives as selective histamine H3 receptor agonists
Grant 8,492,375 - Bruton , et al. July 23, 2
2013-07-23
Piperazine derivative having affinity for the histamine H3 receptor
Grant 8,288,389 - Best , et al. October 16, 2
2012-10-16
1-benzoyl Substituted Diazepine Derivatives As Selective Histamine H3 Receptor Agonists
App 20110039833 - BRUTON; GORDON ;   et al.
2011-02-17
1-benzoyl substituted diazepine derivatives as selective histamine H3 receptor agonists
Grant 7,846,922 - Bruton , et al. December 7, 2
2010-12-07
Piperazine Derivative Having Affinity for the Histamine H3 Receptor
App 20100204242 - Best; Desmond John ;   et al.
2010-08-12
Use Of Quinoline Derivatives In The Treatment Of Pain And Irritable Bowel Syndrome
App 20100041672 - Bruton; Gordon ;   et al.
2010-02-18
Methylene dipiperidine derivatives
Grant 7,638,631 - Bruton , et al. December 29, 2
2009-12-29
Piperazine derivates and their use for the treatment of neurological and psychiatric diseases
Grant 7,592,347 - Bruton , et al. September 22, 2
2009-09-22
Piperazine Derivative Having Affinity For The Histamine H3 Receptor
App 20090170869 - BEST; Desmond John ;   et al.
2009-07-02
Novel Compounds
App 20090042862 - Best; Desmond John ;   et al.
2009-02-12
Bicyclic benzamide compound as histamine H3 receptor ligand useful in the treatment of neurological diseases
Grant 7,446,103 - Best , et al. November 4, 2
2008-11-04
Methylene Dipiperidine Derivatives
App 20080108624 - Bruton; Gordon ;   et al.
2008-05-08
Pyrrolidine Derivatives as Histamine Receptors Ligands
App 20080045506 - Bruton; Gordon ;   et al.
2008-02-21
1-Benzoyl Substituted Diazepine Derivatives As Selective Histamine H3 Receptor Agonists
App 20080045505 - Bruton; Gordon ;   et al.
2008-02-21
Bicyclic Benzamide Compoundssa as Histamine H3 Receptor Ligand Useful in the Treatment of Neurological Diseases
App 20070105838 - Best; Desmond John ;   et al.
2007-05-10
Piperazine derivates and their use for the treatment of neurological and psychiatric diseases
App 20070054917 - Bruton; Gordon ;   et al.
2007-03-08
Substituted piperidines as histamine h3 receptor ligands
App 20060247227 - Bailey; James Matthew ;   et al.
2006-11-02
Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-CD23
Grant 7,045,626 - Best , et al. May 16, 2
2006-05-16
Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies
Grant 7,038,055 - Best , et al. May 2, 2
2006-05-02
Aryloxyalkylamine derivatives as h3 receptor ligands
App 20060052597 - Best; Desmond John ;   et al.
2006-03-09
Bicyclyl or heterobicyclylmethanesulfonylanimo-substituted N-hydroxyformamides
App 20050288376 - Best, Desmond John ;   et al.
2005-12-29
Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23
App 20050085505 - Best, Desmond John ;   et al.
2005-04-21
Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies
App 20050070572 - Best, Desmond John ;   et al.
2005-03-31
(Hetero) bicyclymethanesulfonylamino-substituted hydroxamic acid derivates
App 20040225006 - Bruton, Gordon ;   et al.
2004-11-11
Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
App 20040024066 - Best, Desmond John ;   et al.
2004-02-05
(Hetero) Bicyclymethanesulfonylamino-substituted hydroxamic acid derivatives
App 20030199571 - Bruton, Gordon ;   et al.
2003-10-23
N-sulfonyl hydroxamic acid derivatives as inhibitors of cd23
App 20030195191 - Burton, Gordon ;   et al.
2003-10-16
Novel cd23 inhibitors
App 20030134880 - Bruton, Gordon ;   et al.
2003-07-17
Enantiomers of 1-(3,4-dichlorobenzyl)-2-methylaminoindane
Grant 5,863,952 - Orlek , et al. January 26, 1
1999-01-26
Substituted cycloalkylamine derivatives and their use as calcium channel antagonists
Grant 5,817,698 - Brown , et al. October 6, 1
1998-10-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed